Large language models performed better after full clinical data became available, raising concerns about early triage decision-making.
Category: biotech/medical
Mitochondrial fission helps immune cells kill bacteria and could counter resistance
Alternative therapies that aid the body’s immune system to fight bacteria have shown promise in addressing the global threat of antibiotic resistance. University of Queensland researchers have found when under attack, the body’s immune cells activate a cellular process called mitochondrial fission to kill invading bacteria. Their study is published in the journal Science Immunology.
Dr. James Curson, from UQ’s Institute for Molecular Bioscience, said mitochondrial fission was a critical process in which mitochondria within cells split into smaller units to support the body’s response to stresses, including infections.
“Some bacteria have evolved strategies to stop activation of the mitochondrial fission process—allowing the invading pathogens to survive, and the infection to persist,” Dr. Curson said.
Gene Therapy for Parkinson’s Disease Associated with GBA1 Mutations
Abeliovich et al. make a compelling case for the promise of using gene therapy to treat Parkinson’s disease (PD) patients who possess mutations in the GBA1 gene. People interested in the clinical-translational side of biomedicine should definitely check this out!
This website uses a security service to protect against malicious bots. This page is displayed while the website verifies you are not a bot.
Dyno Therapeutics Launches Two New AAV Capsids and AI Platform for Rare Disease Therapeutic Development at the 2026 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
Dyno continues to develop impressive new AAV capsids with their AI-guided design approach!
About Dyno Therapeutics.
Dyno Therapeutics is on a mission to build high-performance genetic technologies that transform patients’ lives. Dyno applies AI to build technologies for gene delivery and sequence design that advance “Genetic Agency” — an individual’s ability to take action at the genetic level to live a healthier life — through safe, effective and widely accessible genetic treatments. With frontier AI models and high-throughput in vivo experimentation, Dyno designs optimized AAV delivery vectors that solve gene delivery challenges across a wide range of therapeutic applications including eye, muscle and CNS. Dyno partners across industries to ensure these life-transforming technologies can help as many patients as possible, including through strategic collaborations with leading gene therapy developers Astellas and Roche and with technology companies including NVIDIA. Dyno’s AI-designed capsids are available for direct licensing and through the Dyno Frontiers Network. Visit www.dynotx.com for more information.
‘Dyno Therapeutics’, ‘dyno’, the Dyno logo, and mountain logo are registered trademarks of Dyno Therapeutics, Inc. All rights reserved.
A fresh approach to peppermint: 250 new variants could boost flavor and fight disease
The genomics of peppermint are not as fresh as their flavor but scientists from the University of California, Davis, have found a way to breathe new genetic variation into the species. The findings, published in the Proceedings of the National Academy of Sciences, could help the mint industry develop new varieties of peppermint and provide a roadmap for improving clonal crops more generally.
Similar to strawberries, potatoes and many fruit trees, peppermint plants (Mentha × piperita) are reproduced asexually by a process called clonal propagation. In the case of peppermint, this means that their genomes have remained unaltered for more than 200 years. This lack of genetic variation leaves them susceptible to disease and means that properties such as yield and flavor have remained stagnant.
UC Davis plant biologists used radiation to induce mutations in the leading peppermint clone grown in the United States, resulting in more than 250 new and genetically distinct variants. Altogether, they introduced 1,406 large genetic mutations, which can now be used to identify key genes for breeding or selecting new and superior peppermint varieties.
Silk made into strong plastic-like materials with 6G potential
Silk threads can be fused into transparent, plastic-like materials that twist terahertz frequencies of light, according to research led by Imperial College London, University of Michigan Engineering and Tufts University. The findings could enable components of 6G networks to be made from upcycled silk.
The new materials are also lightweight, yet stronger than many metal alloys and conventional plastics produced from fossil fuels. Their mechanical properties could make them useful in sports gear, shipping containers and certain kinds of packaging. In ballistics tests, the new materials were about as puncture-resistant as carbon-fiber-reinforced polymers, which are used in the bodies of airplanes and the chassis of automobiles. And, because the materials slowly degraded when implanted into mice, they could prove useful in temporary medical implants.
The researchers are particularly interested in the material’s ability to twist, or polarize, terahertz frequencies of light. The 6G band, which could transmit data up to hundreds of times faster than 5G networks and is particularly appealing for rural high-speed internet, extends into terahertz frequencies.
Deep Dive: The Agentic AI Economy
The Moat: The moat is no longer how smart your AI is; it’s what your AI is allowed to touch. An agent that has “Write Access” to a company’s internal financial system or a medical record database is 100x more valuable than a “smart” chatbot that can only read public websites. Connectivity is the new Intellectual Property.
In the agentic economy, the most valuable human skill isn’t “coding” or “writing”—it is Agentic Orchestration.
The agentic economy thrives on Data Flywheels. As an agent performs a task (e.g., “Review this legal contract”), it gets human feedback (“This clause was too aggressive”). That feedback isn’t just a correction; it’s training data that makes the agent more valuable for the next task. This creates a winner-take-all dynamic for whoever has the most active agents in a specific niche.
We are moving toward an outcome-based economy. However, the real “gold rush” isn’t in building the smartest AI; it’s in building the safest and most connected AI—the one that humans trust enough to give the “keys” to their bank accounts, their calendars, and their businesses.
4-octyl itaconate inhibits cytokine-mediated inflammation via alkylation of TYK2 and JAK1
Li et al. discovered that 4-octyl itaconate (4-OI) directly covalently modifies TYK2 and JAK1 to inhibit the type I interferon response. Endogenous metabolite itaconate in sepsis is a JAK inhibitor. In the mouse, in vivo experiments, intraperitoneal injection of 4-octyl itaconate could alleviate multi-organ damage caused by sepsis.